(R)-noradrenaline multiple interactions ISO RGD:1316353 6480464 [Dexamethasone co-treated with Norepinephrine] results in increased expression of ELOVL3 mRNA more ... CTD PMID:17726147 (R)-noradrenaline increases expression ISO RGD:1316353 6480464 Norepinephrine results in increased expression of ELOVL3 mRNA CTD PMID:17726147 17beta-estradiol decreases expression ISO RGD:1316353 6480464 Estradiol results in decreased expression of ELOVL3 mRNA CTD PMID:19484750 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ELOVL3 mRNA CTD PMID:21998131 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1316353 6480464 Tetrachlorodibenzodioxin results in decreased expression of ELOVL3 mRNA CTD PMID:28213091 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316353 6480464 Tetrachlorodibenzodioxin affects the expression of ELOVL3 mRNA CTD PMID:26377647 3-methylcholanthrene increases expression ISO RGD:1316353 6480464 Methylcholanthrene results in increased expression of ELOVL3 mRNA CTD PMID:25926378 4-hydroxyphenyl retinamide increases expression ISO RGD:1316353 6480464 Fenretinide results in increased expression of ELOVL3 mRNA CTD PMID:28973697 actinomycin D multiple interactions ISO RGD:1316353 6480464 Dactinomycin inhibits the reaction [Norepinephrine results in increased expression of ELOVL3 mRNA], Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of ELOVL3 mRNA] CTD PMID:17726147 benzo[a]pyrene decreases expression ISO RGD:1316353 6480464 Benzo(a)pyrene results in decreased expression of ELOVL3 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ELOVL3 mRNA CTD PMID:20106945 , PMID:21632981 beta-naphthoflavone decreases expression ISO RGD:1316353 6480464 beta-Naphthoflavone results in decreased expression of ELOVL3 mRNA CTD PMID:28973660 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1316353 6480464 Diethylhexyl Phthalate results in increased expression of ELOVL3 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1316353 6480464 Diethylhexyl Phthalate results in decreased expression of ELOVL3 mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1316353 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ELOVL3 mRNA] CTD PMID:19850644 bisphenol A decreases expression ISO RGD:1307263 6480464 bisphenol A results in decreased expression of ELOVL3 mRNA CTD PMID:25181051 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of ELOVL3 mRNA CTD PMID:26079696 carbon nanotube decreases expression ISO RGD:1316353 6480464 Nanotubes, Carbon analog results in decreased expression of ELOVL3 mRNA, Nanotubes, Carbon results in decreased expression of ELOVL3 mRNA CTD PMID:25620056 ciprofibrate decreases expression ISO RGD:1316353 6480464 ciprofibrate results in decreased expression of ELOVL3 mRNA CTD PMID:12771043 CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE multiple interactions ISO RGD:1316353 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA CTD PMID:16931933 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ELOVL3 mRNA CTD PMID:27392435 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ELOVL3 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:1316353 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:1316353 6480464 Clofibrate results in increased expression of ELOVL3 mRNA CTD PMID:17585979 , PMID:23811191 cycloheximide decreases expression ISO RGD:1316353 6480464 Cycloheximide results in decreased expression of ELOVL3 mRNA CTD PMID:17726147 cycloheximide multiple interactions ISO RGD:1316353 6480464 Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of ELOVL3 mRNA] CTD PMID:17726147 decabromodiphenyl ether decreases expression ISO RGD:1307263 6480464 decabromobiphenyl ether results in decreased expression of ELOVL3 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:1316353 6480464 [Dexamethasone co-treated with Norepinephrine] results in increased expression of ELOVL3 mRNA, rosiglitazone promotes the reaction [[Dexamethasone co-treated with Norepinephrine] results in increased expression of ELOVL3 mRNA] CTD PMID:17726147 dibutyl phthalate increases expression ISO RGD:1316353 6480464 Dibutyl Phthalate results in increased expression of ELOVL3 mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid decreases expression ISO RGD:1316353 6480464 Dichloroacetic Acid results in decreased expression of ELOVL3 mRNA CTD PMID:28962523 ethanol decreases expression ISO RGD:1316353 6480464 Ethanol results in decreased expression of ELOVL3 mRNA CTD PMID:19167417 furan decreases expression ISO RGD:1316353 6480464 furan results in decreased expression of ELOVL3 mRNA CTD PMID:24183702 genistein decreases expression ISO RGD:1316353 6480464 Genistein results in decreased expression of ELOVL3 mRNA CTD PMID:24967385 genistein increases expression EXP 6480464 Genistein results in increased expression of ELOVL3 mRNA CTD PMID:20884965 indinavir multiple interactions ISO RGD:1316353 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA CTD PMID:16931933 lamivudine multiple interactions ISO RGD:1316353 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA more ... CTD PMID:16931933 linalool decreases expression EXP 6480464 linalool results in decreased expression of ELOVL3 mRNA CTD PMID:24752549 lipopolysaccharide decreases expression ISO RGD:1316353 6480464 Lipopolysaccharides results in decreased expression of ELOVL3 mRNA CTD PMID:27339419 mercury dichloride decreases response to substance EXP 6480464 ELOVL3 protein results in decreased susceptibility to Mercuric Chloride CTD PMID:24118919 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of ELOVL3 mRNA CTD PMID:24118919 methotrexate affects expression ISO RGD:1316353 6480464 Methotrexate affects the expression of ELOVL3 mRNA CTD PMID:18502557 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of ELOVL3 mRNA CTD PMID:24118919 methylmercury chloride decreases response to substance EXP 6480464 ELOVL3 protein results in decreased susceptibility to methylmercuric chloride CTD PMID:24118919 N-nitrosodiethylamine decreases expression ISO RGD:1316353 6480464 Diethylnitrosamine results in decreased expression of ELOVL3 mRNA CTD PMID:12771043 , PMID:24535843 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of ELOVL3 mRNA CTD PMID:24768652 nickel sulfate multiple interactions ISO RGD:1316353 6480464 [nickel sulfate co-treated with Particulate Matter] results in decreased expression of ELOVL3 mRNA CTD PMID:23126276 ozone decreases expression ISO RGD:1316353 6480464 Ozone results in decreased expression of ELOVL3 mRNA CTD PMID:16183385 paracetamol multiple interactions ISO RGD:1316353 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:1316353 6480464 Acetaminophen affects the expression of ELOVL3 mRNA CTD PMID:17562736 pentanal increases expression EXP 6480464 pentanal results in increased expression of ELOVL3 mRNA CTD PMID:26079696 phenobarbital multiple interactions ISO RGD:1316353 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ELOVL3 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:1316353 6480464 Phenobarbital affects the expression of ELOVL3 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:1316353 6480464 Phenobarbital results in decreased expression of ELOVL3 mRNA CTD PMID:19270015 , PMID:19482888 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ELOVL3 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1316353 6480464 pirinixic acid results in increased expression of ELOVL3 mRNA CTD PMID:16357043 more ... pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1316353 6480464 Pregnenolone Carbonitrile results in increased expression of ELOVL3 mRNA CTD PMID:28903501 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of ELOVL3 mRNA CTD PMID:26079696 quercetin increases expression EXP 6480464 Quercetin results in increased expression of ELOVL3 mRNA CTD PMID:21632981 resveratrol increases expression ISO RGD:1316353 6480464 resveratrol results in increased expression of ELOVL3 mRNA CTD PMID:25761413 resveratrol multiple interactions ISO RGD:1316353 6480464 PRKAA1 gene mutant form inhibits the reaction [resveratrol results in increased expression of ELOVL3 mRNA] CTD PMID:25761413 saquinavir multiple interactions ISO RGD:1316353 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA CTD PMID:16931933 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of ELOVL3 mRNA CTD PMID:25895662 tamoxifen affects expression ISO RGD:1316353 6480464 Tamoxifen affects the expression of ELOVL3 mRNA CTD PMID:20937368 testosterone increases expression ISO RGD:1316353 6480464 Testosterone results in increased expression of ELOVL3 mRNA CTD PMID:20844152 tetrachloroethene decreases expression ISO RGD:1316353 6480464 Tetrachloroethylene results in decreased expression of ELOVL3 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:1316353 6480464 Carbon Tetrachloride results in decreased expression of ELOVL3 mRNA CTD PMID:27339419 , PMID:29987408 tetrachloromethane multiple interactions ISO RGD:1316353 6480464 PANX1 protein affects the reaction [Carbon Tetrachloride results in decreased expression of ELOVL3 mRNA] CTD PMID:29987408 tetracycline increases expression ISO RGD:1316353 6480464 Tetracycline results in increased expression of ELOVL3 mRNA CTD PMID:16917069 trichloroethene decreases expression ISO RGD:1316353 6480464 Trichloroethylene results in decreased expression of ELOVL3 mRNA CTD PMID:19448997 , PMID:28973375 urethane increases expression EXP 6480464 Urethane results in increased expression of ELOVL3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1316353 6480464 Valproic Acid affects the expression of ELOVL3 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ELOVL3 mRNA CTD PMID:23179753 more ... zidovudine multiple interactions ISO RGD:1316353 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA more ... CTD PMID:16931933 
Gene Ontology Annotations
